Skip to main content
. 2017 Jan 11;8(2):152–161. doi: 10.7150/jca.16523

Figure 1.

Figure 1

(A) Cumulative HCC incidence for all cases (n=338). The 3-, 5- 7-year cumulative HCC incidence rates in all cases were 4.4%, 9.2% and 13.5%, respectively. (B) Cumulative HCC incidence in the high-FIB group (FIB-4 index ≥3.666, n=83) and the low-FIB group (FIB-4 index <3.666, n=255). The 3-, 5- 7-year cumulative HCC incidence rates were 11.26%, 25.28% and 32.10%, respectively, in the H-FIB group, and 2.09%, 3.99% and 7.48%, respectively, in the L-FIB group (P<0.0001). (C) Cumulative HCC incidence in the H- APRI group (APRI ≥0.786, n=188) and the L-APRI group (APRI <0.786, n=150). The 3-, 5- 7-year cumulative HCC incidence rates were 6.63%, 13.37% and 18.49%, respectively, in the H-APRI group, and 1.45%, 3.71% and 6.85%, respectively, in the L-APRI group (P=0.0027).